2-[4-(2-hydroxyethyl)diazepan-1-yl]-1-phenyl-1H-indole-3-carboxaldehyde | 847802-05-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 2-[4-(2-hydroxyethyl)diazepan-1-yl]-1-phenyl-1H-indole-3-carboxaldehyde
• 英文别名: 2-[4-(2-Hydroxyethyl)-1,4-diazepan-1-yl]-1-phenylindole-3-carbaldehyde
• CAS: 847802-05-5
• 化学式: C₂₂H₂₅N₃O₂
• 分子量: 363.459
• InChiKey: QZVVLFUCDWXDPC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  48.7
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• SUBSTITUTED AZA-INDOLES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP)
  申请人：JIANG John Z.

  公开号：US20080255350A1

  公开（公告）日：2008-10-16

  The present invention relates to a series of substituted aza-indole derivatives of the formula I: wherein R, R 1 , R 2 , R 3 , R 4 , X and Y are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5′-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.

  本发明涉及一系列式I的取代杂氮吲哚衍生物，其中R、R1、R2、R3、R4、X和Y的定义如本文所述。本发明还涉及制备这些化合物的方法。本发明的化合物是聚腺苷酸二磷酸核糖聚合酶（PARP）的抑制剂，因此在治疗和/或预防包括与中枢神经系统和心血管疾病相关的各种疾病方面，特别是作为药物制剂，具有重要的用途。
• US7405300B2
  申请人：——

  公开号：US7405300B2

  公开（公告）日：2008-07-29
• US8008491B2
  申请人：——

  公开号：US8008491B2

  公开（公告）日：2011-08-30
• [EN] SUBSTITUTED INDOLES AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP)<br/>[FR] INDOLES SUBSTITUES COMME INHIBITEURS DE POLYMERASE DE POLY(ADP-RIBOSE) (PARP)
  申请人：AVENTIS PHARMA INC

  公开号：WO2005023246A1

  公开（公告）日：2005-03-17

  The present invention relates to a series of substituted indole derivatives of the formula I as described herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5’-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.